Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Med (New York, N.Y.)
|
May 10, 2025
The impact of real-world evidence in implementing and optimizing Alzheimer's disease care
Harald Hampel, Gang Li, Michelle M Mielke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2006
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents
James R Henry, Yihong Li, Alan M Warshawsky, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 2, 2015
Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib
Evelyn M McKeegan, Peter J Ansell, Gerard Davis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 27, 2025
Risk prediction of mild cognitive impairment using electronic health record data
Gang Li, Bryan Cobb, Todd M Nelson, et al.
Pharmaceutical Research
|
January 7, 2006
Fit-for-purpose method development and validation for successful biomarker measurement
Jean W Lee, Viswanath Devanarayan, Yu Chen Barrett, et al.
Mabs
|
March 5, 2024
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals
Sophie Tourdot, Daniel Baltrunkonis, Sofie Denies, et al.
Journal of Immunological Methods
|
February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
Eugen Koren, Holly W Smith, Elizabeth Shores, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer
Suresh S Ramalingam, Mikhail Shtivelband, Ross A Soo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates
Sethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Nature Biotechnology
|
August 25, 2014
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
Charles Wang, Binsheng Gong, Pierre R Bushel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Med (New York, N.Y.)
|
May 10, 2025
The impact of real-world evidence in implementing and optimizing Alzheimer's disease care
Harald Hampel, Gang Li, Michelle M Mielke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 29, 2006
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents
James R Henry, Yihong Li, Alan M Warshawsky, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 2, 2015
Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib
Evelyn M McKeegan, Peter J Ansell, Gerard Davis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 27, 2025
Risk prediction of mild cognitive impairment using electronic health record data
Gang Li, Bryan Cobb, Todd M Nelson, et al.
Pharmaceutical Research
|
January 7, 2006
Fit-for-purpose method development and validation for successful biomarker measurement
Jean W Lee, Viswanath Devanarayan, Yu Chen Barrett, et al.
Mabs
|
March 5, 2024
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals
Sophie Tourdot, Daniel Baltrunkonis, Sofie Denies, et al.
Journal of Immunological Methods
|
February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
Eugen Koren, Holly W Smith, Elizabeth Shores, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer
Suresh S Ramalingam, Mikhail Shtivelband, Ross A Soo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates
Sethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Nature Biotechnology
|
August 25, 2014
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
Charles Wang, Binsheng Gong, Pierre R Bushel, et al.
Page
of 7